文献速递眼底病与葡萄膜炎

城市学术中心中以超广角成像诊断的去羟肌苷相关视网膜毒性患病率

PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING.
PubMed 文献 · Retina · 2024-01-01

这项回顾性病例系列分析了Weill Cornell医学眼科127例接受去羟肌苷(DDI)治疗的患者,其中9例(7%)出现DDI诱导的视网膜毒性。患者年龄较大、BMI较低及开始治疗时年龄较大与视网膜毒性相关,超广角自发荧光有助于检测和描绘病变。作者认为需要随访研究以确定对DDI使用中或既往使用者进行定期筛查的必要性。

要点

  • 127例DDI治疗患者中9例(7%)出现DDI诱导的视网膜毒性。
  • 受影响组较未受影响组年龄更大(65.1 vs 56.5岁,P=0.025)、BMI更低(23.2 vs 27.4,P=0.04)、开始治疗时年龄更大(51.6 vs 40.8岁,P=0.026)。
  • 超广角自发荧光有助于检测和描绘周边色素性改变等轻度表型。

核心结论

  • 这项学术研究揭示了DDI诱导的视网膜毒性存在值得注意的患病率。
  • 统计分析显示年龄、BMI和开始治疗时年龄是潜在危险因素。
  • 超广角自发荧光成为检测和描绘病变的有价值工具。
  • 需要随访研究以确定对DDI使用中或既往使用者进行定期筛查的必要性。

研究设计与样本

  • 回顾性病例系列,分析Weill Cornell Medicine眼科127例接受DDI治疗的患者。
  • 纳入标准包括DDI使用至少6个月且可获得超广角成像。
  • 由两名评审者根据视网膜成像将患者分为受影响组和未受影响组,受影响组进一步分为「 probable 」或「 possible 」视网膜病变。

主要发现

  • 127例患者中9例(7%)显示DDI诱导的视网膜毒性征象。
  • 受影响组平均年龄大于未受影响组(65.1 vs 56.5岁,P=0.025)。
  • 受影响组BMI低于未受影响组(23.2 vs 27.4,P=0.04)。
  • 受影响组开始治疗时年龄大于未受影响组(51.6 vs 40.8岁,P=0.026)。
  • 使用超广角成像还识别出伴有周边色素性改变的轻度表型。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Antiretroviral therapy has revolutionized HIV treatment with didanosine (DDI) as a pioneering drug. However, DDI has been associated with retinal toxicity, characterized by peripheral chorioretinal degeneration with macular sparing. Despite its clinical recognition, the prevalence and risk factors for didanosine-induced retinopathy are not well described. METHODS: This retrospective case series analyzed 127 DDI-treated patients at Weill Cornell Medicine Department of Ophthalmology. Inclusion criteria included at least 6 months of DDI use and available ultra-widefield imaging. Patients were categorized as affected or unaffected based on retinal imaging assessed by two reviewers. The affected group was further divided into "probable" or "possible" retinopathy. Patient demographics, DDI usage characteristics, and imaging findings were analyzed with statistical comparisons drawn between affected and unaffected cohorts. RESULTS: Of the 127 patients, 9 (7%) showed signs of didanosine-induced retinal toxicity. On average, the affected group was older compared with the unaffected group (65.1 vs. 56.5 years, P = 0.025), with lower BMI (23.2 vs. 27.4, P = 0.04), and older at the start of the treatment (51.6 vs. 40.8 years, P = 0.026). Mild phenotypes with peripheral pigmentary changes were also identified using ultra-widefield imaging. CONCLUSION: This pioneering academic study highlighted a notable prevalence of DDI-induced retinal toxicity. Statistical analysis demonstrated age, BMI, and age at treatment initiation as potential risk factors. Ultra-widefield autofluorescence emerged as a valuable tool in detecting and delineating findings. Follow-up studies are needed to determine the necessity of regular screening for individuals on or with a history of didanosine use.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Kim JS, Shah J, Papakostas T, et al. PREVALENCE OF DIDANOSINE-RELATED RETINAL TOXICITY AT AN URBAN ACADEMIC CENTER AS DIAGNOSED WITH ULTRA-WIDEFIELD IMAGING. Retina. 2024. PMID: 39287547. doi:10.1097/IAE.0000000000004175

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。